The lipidomic and inflammatory profiles of visceral and subcutaneous adipose tissues are distinctly regulated by the SGLT2 inhibitor empagliflozin in Zucker diabetic fatty rats-Reference-Cited by-同舟云学术

The lipidomic and inflammatory profiles of visceral and subcutaneous adipose tissues are distinctly regulated by the SGLT2 inhibitor empagliflozin in Zucker diabetic fatty rats

Published:2023-05 Issue: Volume:161 Page:114535
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Aragón-Herrera Alana,Moraña-Fernández Sandra,Otero-Santiago Manuel,Anido-Varela Laura,Campos-Toimil Manuel,García-Seara Javier,Román Ana,Seijas José,García-Caballero Lucía,Rodríguez Javier,Tarazón Estefanía,Roselló-Lletí Esther,Portolés Manuel,Lage Ricardo,Gualillo Oreste,González-Juanatey José Ramón,Feijóo-Bandín Sandra^ORCID,Lago Francisca

Funder

Carlos III Health Institute

Axencia Galega de Innovación

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference80 articles.

1. SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications;Brown;Lancet,2021

2. Renal effects of SGLT2 inhibitors in cardiovascular patients with and without chronic kidney disease: focus on heart failure and renal outcomes;Gronda;Heart Fail. Rev.,2022

3. Empagliflozin in heart failure with a preserved ejection fraction;Anker;N. Engl. J. Med.,2021

4. Differential pathophysiological mechanisms in heart failure with a reduced or preserved ejection fraction in diabetes;Packer;JACC Heart Fail.,2021

5. Low-grade inflammation as a risk factor for cardiovascular events and all-cause mortality in patients with type 2 diabetes;Sharif;Cardiovasc. Diabetol.,2021

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating the potential impact of sodium–glucose cotransporter‐2 inhibitor “canagliflozin” on the hepatic damage triggered by hypertension in rats;Microscopy Research and Technique;2024-07-25

2. Sodium-glucose cotransporter 2 inhibitors induce anti-inflammatory and anti-ferroptotic shift in epicardial adipose tissue of subjects with severe heart failure;Cardiovascular Diabetology;2024-06-28

3. Novel Therapeutics for Type 2 Diabetes Mellitus—A Look at the Past Decade and a Glimpse into the Future;Biomedicines;2024-06-21

4. Female and male obese Zucker rats display differential inflammatory mediator and long non-coding RNA profiles;Life Sciences;2023-12

5. Lipid remodeling of adipose tissue in metabolic health and disease;Experimental & Molecular Medicine;2023-09-01